Biologics in Otolaryngology, An Issue of Otolaryngologic Clinics of North America, 1st Edition
Author :
Edited by Sarah K. Wise, MD, Ashkan Monfared, MD and Nicole Schmitt, MD
This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Ch
...view more
This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.
This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.
Author Information
Edited by Sarah K. Wise, MD, Professor
Department of Otolaryngology–Head and Neck
Emory University
Atlanta, GA, USA; Ashkan Monfared, MD, Directory of Otology and Neurotology
The George Washington Medical Faculty Associates
Washington, DC, USA and Nicole Schmitt, MD, Department of Otolaryngology-Head and Neck Surgery, Emory University
Edited by Sarah K. Wise, MD, Professor
Department of Otolaryngology–Head and Neck
Emory University
Atlanta, GA, USA; Ashkan Monfared, MD, Directory of Otology and Neurotology
The George Washington Medical Faculty Associates
Washington, DC, USA and Nicole Schmitt, MD, Department of Otolaryngology-Head and Neck Surgery, Emory University
Biologics in Otolaryngology: Past, Present, and Future Current Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis Choosing the Right Patient for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis: Endotypes, Patient Characteristics, and Defining Failures of Standard Therapy Knowledge Gaps and Research Needs for Biologic Therapy in Rhinology Practice Mechanisms and Practical Use of Biologic Therapies for Allergy and Asthma Indications Immunotherapeutic Strategies for Head and Neck Cancer Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer: Biomarkers of Response and Resistance Advances in Adoptive Cell Therapy for Head and Neck Cancer Biologics for the Treatment of Recurrent Respiratory Papillomatosis Past and Future Biologics for Otologic Disorders Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders Biologics for Immune-Mediated Sensorineural Hearing Loss Women in Academic Medicine and Leadership Balance Versus Integration: Work-Life Considerations
https://www.asia.elsevierhealth.com/biologics-in-otolaryngology-an-issue-of-otolaryngologic-clinics-of-north-america-9780323835367.html297714Biologics in Otolaryngology, An Issue of Otolaryngologic Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323835367_105.jpg89.0998.99USDInStock/Clinics/Medicine & Surgery/Otolaryngology/Medicine/Otolaryngology/Clinics/Clinics/Medicine/Otolaryngology/Japan Titles43887254335141505461750546665255041525990452631601418269243350884886536505455351451205259833<P>This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.</P> <P>This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.</P>00add-to-cart97803238353672021ProfessionalEdited by Sarah K. Wise, MD, Ashkan Monfared, MD and Nicole Schmitt, MD20211Book152w x 229h (6.00" x 9.00")Elsevier240Jul 15, 2021IN STOCKEdited by <STRONG>Sarah K. Wise</STRONG>, MD, Professor
Department of Otolaryngology–Head and Neck
Emory University
Atlanta, GA, USA; <STRONG>Ashkan Monfared</STRONG>, MD, Directory of Otology and Neurotology
The George Washington Medical Faculty Associates
Washington, DC, USA and <STRONG>Nicole Schmitt</STRONG>, MD, Department of Otolaryngology-Head and Neck Surgery, Emory UniversityClinicsClinicsThe Clinics: SurgeryUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
